IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells

Journal of Cellular Physiology

Volumn 212, Issue 3, 2007, Pages 666-674

  Lin, Cheng Wei ^a   Yang, Liang Yo ^a   Shen, Shing Chuan ^b,c   Chen, Yen Chou ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 HYDROXYFLAVONE; ACETYLCYSTEINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BAICALEIN; BAICALIN; ESTRADIOL; ESTROGEN RECEPTOR; FLAVONOID; FULVESTRANT; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PROTEIN C JUN; QUERCETIN; QUERCITRIN; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE; TIRON;

ARTICLE; BREAST CARCINOMA; CELL PROLIFERATION; CHEMICAL STRUCTURE; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; STRUCTURE ACTIVITY RELATION;

ACETYLCYSTEINE; ANTHRACENES; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTRADIOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLAVANONES; FLAVONOIDS; GLYCOSIDES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE KINASES; MOLECULAR STRUCTURE; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-JUN; QUERCETIN; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TIRON; TRANSFECTION;

EID: 34547927628     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21061     Document Type: Article

References (58)

1. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Remesy C, Chap H, Payrastre B. 1997. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53:1649-1657.
2. Babu BH, Jayram HN, Nair MG, Ajaikumar KB, Padikkala J. 2003. Free radical scavenging, antitumor and anticarcinogenic activity of gossypin. J Exp Clin Cancer Res 22:581-589.
3. Cao G, Sofic E, Prior RL. 1997. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med 22:749-760.
4. Chen CW, Oberley TD, Roy D. 1996. Inhibition of stilbene estrogen-induced cell proliferation of renal epithelial cells through the modulation of insulin-like growth factor-I receptor expression. Cancer Lett 105:51-59.
5. Chen KC, Zhou Y, Xing K, Krysan K, Lou MF. 2004. Platelet derived growth factor (PDGF)-induced reactive oxygen species in the lens epithelial cells: the redox signaling. Exp Eye Res 78:1057-1067.
6. Chen YC, Shen SC, Chow JM, Ko CH, Tseng SW. 2004. Flavone inhibition of tumor growth via apoptosis in vitro and in vivo. Int J Oncol 25:661-670.
7. Chen TJ, Jeng JY, Lin CW, Wu CY, Chen YC. 2006. Quercetin inhibition of ROS-dependent and -independent apoptosis in rat glioma C6 cells. Toxicology 223:113-126.
8. 2-induced apoptosis via anti-oxidant activity and heme oxygenase I gene expression in macrophages. Biochem Pharmacol 69:1839-1851.
9. Colavitti R, Pani G, Bedogni B, Anzevino R, Borrello S, Waltenberger J, Galeotti T. 2002. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem 277:3101-3108.
10. Dupont J, Karas M, LeRoith D. 2000. The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components. J Biol Chem 275:35893-35901.
11. Felty Q, Xiong WC, Sun D, Sarkar S, Singh KP, Parkash J, Roy D. 2005. Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers. Biochemistry 44:6900-6909.
12. Guo S, Bezard E, Zhao B. 2005. Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. Free Radic Biol Med 39:682-695.
13. Hall JM, Couse JF, Korach KS. 2001. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276:36869-36872.
14. Hamelers IH, van Schaik RF, van Teeffelen HA, Sussenbach JS, Steenbergh PH. 2002. Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells. Exp Cell Res 273:107-117.
15. Han SS, Keum YS, Seo HJ, Surh YJ. 2002. Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol 35:337-342.
16. Han HJ, Heo JS, Lee YJ. 2005. Estradiol-17beta stimulates proliferation of mouse embryonic stem cells: involvement of MAPKs and CDKs as well as protooncogenes. Am J Physiol Cell Physiol 290:C1067-C1075.
17. Harris GK, Qian Y, Leonard SS, Sbarra DC, Shi X. 2006. Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells. J Nutr 136:1517-1521.
18. Hintz KK, Ren J. 2004. Phytoestrogenic isoflavones daidzein and genistein reduce glucose-toxicity-induced cardiac contractile dysfunction in ventricular myocytes. Endocrinol Res 30:215-223.
19. Houstis N, Rosen ED, Lander ES. 2006. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440:944-948.
20. Hwang YS, Jeorig M, Park JS, Kim MH, Lee DB, Shin BA, Mukaida N, Ellis LM, Kim HR, Ahn BW, Jung YD. 2004. Interleukin-1beta stimulates IL-8 expression through MAP kinase and ROS signaling in human gastric carcinoma cells. Oncogene 23:6603-6611.
21. Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, Grohe C. 2000. Estrogen receptor alpha rapidly activates the IGF-I receptor pathway. J Biol Chem 275:18447-18453.
22. Keshamouni VG, Mattingly RR, Reddy KB. 2002. Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-delta. J Biol Chem 277:22558-22565.
23. Kim B, van Golen CM, Feldman EL. 2004. Insulin-like growth factor-I signaling in human neuroblastoma cells. Oncogene 23:130-141.
24. Kimura A, Ohmichi M, Kawagoe J, Kyo S, Mabuchi S, Takahashi T, Ohshima C, Arimoto-Ishida E, Nishio Y, Inoue M, Kurachi H, Tasaka K, Murata Y. 2004. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene 23:4505-4515.
25. Klotz DM, Hewitt SC, Ciana P, Raviscioni M, Lindzey JK, Foley J, Maggi A, DiAugustine RP, Korach KS. 2002. Requirement of estrogen receptor-alpha in insulin-like growth factor-I (IGF-I)-induced uterine responses and in vivo evidence for IGF-I/estrogen receptor cross-talk. J Biol Chem 277:8531-8537.
26. Ko CH, Shen SC, Lin HY, Hou WC, Lee WR, Yang LL, Chen YC. 2002. Flavanones structure-related inhibition on TPA-induced tumor promotion through suppression of extracellular signal-regulated protein kinases: involvement of prostaglandin E2 in anti-promotive process. J Cell Physiol 193:93-102.
27. Ko CH, Shen SC, Chen YC. 2004. Hydroxylation at C4′ or C6 is essential for apoptosis-inducing activity of flavanone through activation of the caspase-3 cascade and production of reactive oxygen species. Free Radic Biol Med 36:897-910.
28. Ko CH, Shen SC, Hsu CS, Chen YC. 2005a. Mitochondrial-dependent, reactive oxygen species-independent apoptosis by myricetin: roles of protein kinase C, cytochrome c, and caspase cascade. Biochem Pharmacol 69:913-927.
29. Ko CH, Shen SC, Lee TJ, Chen YC. 2005b. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol Cancer Ther 4:281-290.
30. Lai A, Sarcevic B, Prall OW, Sutherland RL. 2001. Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21 (WAF1/Cip1). J Biol Chem 276:25823-25833.
31. Lassarre C, Ricort JM. 2003. Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway. Endocrinology 144:4811-4819.
32. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D. 1999. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol 13:787-796.
33. Lim KT, Cosgrave N, Hill AD, Young LS. 2006. Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1. Breast Cancer Res 8:R33.
34. Lin HY, Juan SH, Shen SC, Hsu FL, Chen YC. 2003. Inhibition of lipopolysaccharide-induced nitric oxide production by flavonoids in R AW264.7 macrophages involves heme oxygenase-1. Biochem Pharmacol 66:1821-1832.
35. Liu SL, Lin X, Shi DY, Cheng J, Wu CQ, Zhang YD. 2002. Reactive oxygen species stimulated human hepatoma cell proliferation via cross-talk between PI3-K/PKB and JNK signaling pathways. Arch Biochem Biophys 406:173-182.
36. Lo YY, Cruz TF. 1995. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J Biol Chem 270:11727-11730.
37. Lozano C, Torres JL, Julia L, Jimenez A, Centelles JJ, Cascante M. 2005. Effect of new antioxidant cysteinyl-flavanol conjugates on skin cancer cells. FEBS Lett 579:4219-4225.
38. Lu J, Papp LV, Fang J, Rodriguez-Nieto S, Zhivotovsky B, Holmgren A. 2006. Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Cancer Res 66:4410-4418.
39. Mahn K, Borras C, Knock GA, Taylor P, Khan IY, Sugden D, Poston L, Ward JP, Sharpe RM, Vina J, Aaronson PI, Mann GE. 2005. Dietary soy isoflavone induced increases in antioxidantand eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J 19:1755-1757.
40. Mawson A, Lai A, Carroll JS, Sergio CM, Mitchell CJ, Sarcevic B. 2005. Estrogen and insulin/IGF-I cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1. Mol Cell Endocrinol 229:161-173.
41. Morelli C, Garofalo C, Sisci D, del Rincon S, Cascio S, Tu X, Vecchione A, Sauter ER, Miller WHJr, Surmacz E. 2004. Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters. Oncogene 23:7517-7526.
42. Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. 2004. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis 25:647-659.
43. Park CH, Lee JH, Yang CH. 2005. Curcumin derivatives inhibit the formation of Jun-Fos-DNA complex independently of their conserved cysteine residues. J Biochem Mol Biol 38:474-480.
44. Plumb GW, Price KR, Williamson G. 1999. Antioxidant properties of flavonol glycosides from green beans. Redox Rep 4:123-127.
45. Regev-Shoshani G, Shoseyov O, Bilkis I, Kerem Z. 2003. Glycosylation of resveratrol protects it from enzymic oxidation. Biochem J 15:157-163.
46. Shen SC, Chen YC, Hsu FL, Lee WR. 2003. Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase 3 cascade. J Cell Biochem 89:1044-1055.
47. Shen SC, Ko CH, Tseng SW, Tsai SH, Chen YC. 2004a. Structurally related antitumor effects of flavanones in vitro and in vivo: involvement of caspase 3 activation, p21 gene expression, and reactive oxygen species production. Toxicol Appl Pharmacol 197:84-95.
48. Shen SC, Ko CH, Hsu KC, Chen YC. 2004b. 3-OH flavone inhibition of epidermal growth factor-induced proliferaton through blocking prostaglandin E2 production. Int J Cancer 108:502-510.
49. Sturrock A, Cahill B, Norman K, Huecksteadt TP, Hill K, Sanders K, Karwande SV, Stringham JC, Bull DA, Gleich M, Kennedy TP, Hoidal JR. 2006. Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 290:L661-L673.
50. Suzukawa K, Miura K, Mitsushita J, Resau J, Hirose K, Crystal R, Kamata T. 2000. Nerve growth factor-induced neuronal differentiation requires generation of Rac1-regulated reactive oxygen species. J Biol Chem 275:13175-13178.
51. Tang HY, Lin HY, Zhang S, Davis FB, Davis PJ. 2004. Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 145:3265-3272.
52. Thiruchelvam M, Prokopenko O, Cory-Slechta DA, Richfield EK, Buckley B, Mirochnitchenko O. 2005. Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype. J Biol Chem 280:22530-22539.
53. Thomas W, Coen N, Faherty S, Flatharta CO, Harvey BJ. 2006. Estrogen induces phospholipase A2 activation through ERK1/2 to mobilize intracellular calcium in MCF-7 cells. Steroids 71:256-265.
54. Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, Brazier M. 2004. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. J Cell Biochem 92:285-295.
55. Wijetunge S, Lymn JS, Hughes AD. 2000. Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60(c-src) kinase activity. Br J Pharmacol 129:1347-1354.
56. Zhang S, Li X, Burghardt R, Smith R3rd, Safe SH. 2005. Role of estrogen receptor (ER)alpha in insulin-like growth factor (IGF)-I-induced responses in MCF-7 breast cancer cells. J Mol Endocrinol 35:433-447.
57. Zhu X, Lee HG, Moreira PI, Smith MA, Perry G. 2006. Presenilin mutation: a deadly first hit in Alzheimer disease. A commentary on "aging sensitizes towards ROS formation and lipid peroxidation in PS1M146L transgenic mice". Free Radic Biol Med 40:737-739.
58. Zivadinovic D, Watson CS. 2005. Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res 7:R130-R144.